LARLLT (TFA)
LARLLT TFA is an EGFR-binding peptide. LARLLT has the potential for research of EGFR overexpressing cancers, such as lung, ovarian and colorectal cancer[1].
Product Specifications
UNSPSC
12352209
Target
EGFR
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Purity
99.89
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(N[C@@H](C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H]([C@H](O)C)C(O)=O)=O)=O)=O)=O)[C@H](CC(C)C)N.OC(C(F)(F)F)=O
Molecular Formula
C33H60F3N9O10
Molecular Weight
799.88
References & Citations
[1]Mayr J, et al. EGFR-targeting peptide-coupled platinum (IV) complexes. J Biol Inorg Chem. 2017 Jun; 22 (4) :591-603.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E2780-01 100 mg
(R, R) - (-) -1, 2-Ethanediylbis[ (2-methoxyphenyl) phenylphosphine
Sign In for Pricing
View Details E2780-02 500 mg
(R, R) - (-) -1, 2-Ethanediylbis[ (2-methoxyphenyl) phenylphosphine
Sign In for Pricing
View Details 
MBS1056127-01 0.02 mg (E-Coli)
Recombinant Proteus mirabilis UPF0434 protein PMI0721 (PMI0721)
Sign In for Pricing
View Details MBS1056127-02 0.1 mg (E-Coli)
Recombinant Proteus mirabilis UPF0434 protein PMI0721 (PMI0721)
Sign In for Pricing
View Details